Japan OTC Retail, Advertising Barriers Should Be Addressed By USTR – CHPA
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association urges the U.S. Trade Representative in recent comments "to draw attention to OTC medicine distribution restrictions" in Japan as an "indirect barrier to market entry" in its upcoming annual report on foreign trade barriers
You may also be interested in...
Japanese Ministry Of Health Looks To Revise OTC Retailing Regulations
Risk-based classification for OTC drugs in Japan is an issue that will figure prominently during a Nov. 15 meeting of a Working Group established by the government's "Task Force to Study Pharmaceutical Retailing.
Japanese Ministry Of Health Looks To Revise OTC Retailing Regulations
Risk-based classification for OTC drugs in Japan is an issue that will figure prominently during a Nov. 15 meeting of a Working Group established by the government's "Task Force to Study Pharmaceutical Retailing.
Japanese Ministry Of Health Looks To Revise OTC Retailing Regulations
Risk-based classification for OTC drugs in Japan is an issue that will figure prominently during a Nov. 15 meeting of a Working Group established by the government's "Task Force to Study Pharmaceutical Retailing.